EAM Investors, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 66 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 2.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$1,389,000
-8.2%
218,429
-31.6%
0.22%
-13.1%
Q1 2018$1,513,000
-39.0%
319,187
+97.1%
0.25%
-43.6%
Q1 2014$2,479,000
+62.7%
161,935
+5.9%
0.45%
+47.0%
Q3 2013$1,524,000152,8540.30%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$276,0000.10%
Geneos Wealth Management Inc. 445,200$725,0000.05%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$20,0000.01%
Vivaldi Capital Management LP 19,261$30,0000.01%
Atria Wealth Solutions, Inc. 278,700$454,2810.01%
OSAIC HOLDINGS, INC. 1,302,122$2,123,0000.01%
BARRETT & COMPANY, INC. 4,984$5,6320.00%
Ameritas Advisory Services, LLC 45,302$74,0000.00%
CENTAURUS FINANCIAL, INC. 20,732$34,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 19,255$31,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders